Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG

Erlangen, 19 December 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company that manufactures implants for eye surgery, was informed today that the following companies are behind the Company's new majority shareholder - HumanOptics Holding AG, Berlin - and that the following Chinese private individual is at the end of the shareholding chain: Legend Medical Investment Ltd., Tortola, British Virgin Islands;
Legend Medical Investment (Hong Kong) Limited, Hong Kong; Hunan Liangjing Medical Management Co, Changsha, Hunan Province, China; Shanghai Qilin Medical Technology Co., Ltd, Shanghai, China; LI Lijuan, Shanghai, China.

Contact:

HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: [email protected]